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Abstract 
Two sets of animal experiments using guinea 
pigs were planned to evaluate the effect of 
ascorbic acid supplementation on the lithogenic 
process. In the first set of experiments, 10, 40, 
and 60 mg doses of ascorbic acid/lOOg body 
weight/day were given fur 105 days. Neither of 
the ascorbic acid doses given induced 
crystalluria, calcification or stone formation, 
thereby confirming our previous findings that 
ascorbic acid in the doses used by clinicians 
does not cause urolith formation. In the second 
set of experiments, ascorbic acid was 
supplemented in hypercalciuric (induced by 
calcium carbonate feeding) and hyperoxaluric 
(induced by sodium oxalate feeding) animals for 
45 days. The results indicated that it 
exacerbated the calcification process in renal 
and bladder tissue. 
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Introduction 
While the perils of ascorbic acid deficiency 
are well established, the dangers of its 
excessive intake especially in relation to 
oxaluria and urolithiasis is still a 
controversial issue. This needs to be carefully 
examined as there is an increasing tendency among 
the health conscious people of self medication 
with high ascorbic acid doses with a notion to 
tone up the body resistance system and by the 
clinicians to provide better protection against 
infection, cold, cancer, atherosclerosis, 
tuberculosis and metal poisoning (Pauling, 1970; 
Krupp et al . 1986). Also, ascorbic acid is 
considered as one of the safest and best chemical 
for acidifying the urine (Krupp et al. 1986). 
A number of workers have reported 
hyperoxaluria on heavy ascorbic acid dosing 
( Chalmers et al. 1986; Pendse et al. 1985 and 
Schmidt et al. 1981). Although, to this date, 
there is no direct evidence of ascorbic acid 
dosing at any length of time leading to stone 
furmation in human beings but Smith et al. (1978) 
suggested such a possibility in some renal stone 
patients. Briggs et al. (1973) felt that some 
individuals could be over sensitive to oxalate 
synthesis from ascorbic acid and might suffer 
from renal calcification/ stones on higher doses 
of ascorbic acid. 
On the other hand, Hoffer (1971) questioned 
the validity of the above said belief on the 
basis of his experience stretching over 18 years 
in which he gave 3-30g ascorbic acid daily to 
over 1000 patients for prolonged periods. He did 
not come across a single case of stone formation 
or of any other serious toxicity. Our studies on 
rats also suggested the same view (Singh et al. 
1988). Since the rat can synthesize ascorbic 
acid, we decided to extend our study to guinea 
pigs whose ascorbic acid metabolism is similar to 
man. In addition to this, we also examined its 
effect under the condition that when the diet 
contained a higher content of calcium, a 
condition frequently visible in the diet of 
western subjects and a higher content of oxalic 
acid, a condition occasionally seen in the Indian 
population (Singh et al. 1972, 1986 and 1990). 
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Material and Methods 
Male guinea pigs (Cavia porcellus) of an 
inbred strain (Wt. 340-380 gm) were selected. 
They were given a standard basal diet, commencing 
two weeks prior to experimentation to mitigate 
the effect of their previous diet, if any, and 
during experimental period. 
Experimental protocol. Animals were divided 
into 8 groups of 7 animals each. Group I - Basal 
diet; Group II - basal diet+ 10 mp, ascorbic acid 
/100 g body weight; Group III - basal diet+ 40 
mg ascorbic acid/100 g body weight; Group IV -
basal diet + 60 mg ascorbic acid/100 g/body 
weight; Group V - basal diet + 2% Calcium 
carbonate; Group VI - basal diet + 2% calcium 
carbonate + 10 mg ascorbic acid/100 g/body 
weight; Group VII - basal diet + 3% sodium 
oxalate; Group VIII - basal diet + 3% sodium 
oxalate+ 10 mg ascorbic acid/100 g/body weight. 
Sodium oxalate and calcium carbonate were given 
as a mixture with diet. 
Food and water were given ad libitum. Food 
intake was noted daily and body weight was 
recorded twice a week. Physical and behavioural 
appearances were observed everyday. The ascorbic 
acid was dissolved in water and was orally given 
by introducing a 17 gauge endoesophagial tube 
into the stomach through the mouth and the 
solution was instilled using a syringe. The 
duration of study was 105 days in group 1-3 and 
45 days in group 4-7. 
Collection of urine samples. The initial 24 
hr urine samples were collected before any 
supplementation. Post load samples were collected 
at interval of 15 days. 0.3 mmol EDTA (sodium 
salt) was added in collection bottles to prevent 
the conversion of ascorbic acid to oxalic acid 
(Chalmers et al. 1985). Urine samples were 
transferred to collection bottles. Trays were 
rinsed with double distilled water and contents 
were transferred to collection bottles. Final 
volume of all urine samples was raised to 25 ml. 
All the samples were analysed for creatinine, 
ascorbic acid, phosphorus, magnesium, uromucoid 
(Natelson, 1971), calcium (Gindler and King, 
1972), uric acid (Caraway, 1955), citric acid 
(Rajagopal, 1984) and oxalic acid (Hodgkinson 
and Williams, 1972). The pH of fresh urine was 
measured by narrow range BDH pH strips. 
Histological study. The histological 
sections of kidney and bladder were cut on the 
microtome and the sections were stained with Von 
Kossa solution. 
Statistical evaluation was carried out by 
employing paired 't' tests. 
Results 
The results of the effect of supple-
mentation of 10, 40, and 60 mg ascorbic acid/ 
100 g body Wt./day are given in Tables 1-
3. There was a significant drop in urinary pH 
after supplementation of ascorbic acid in all 
the experimental groups though at different 
periods of time. Higher doses of ascorbic acid 
(40 and 60 mg) induced increased oxalic acid 
excretion and decreased citric acid, calcium and 
magnesium excretion at different periods of time 
(Tables 2 and 3). Other parameters remained 
unaltered and so was the picture of crystalluria. 
The ascorbic acid excretion significantly 
increased in all the groups. The results of 2% 
calcium carbonate and 3% sodium oxalate with and 
without ascorbic acid supplementation are given 
in Tables 4-7. Their feeding increased calcium 
and oxalic acid excretion respectively. Ascorbic 
acid supplementation did not influence urine 
chemistry in either group but histological 
examination revealed that ascorbic acid 
intensified the renal and biadder tissue 
calcification in both the groups (Figs. 1-2). 
Urinary calcium/citrate and calcium/magnesium 
ratio remained unaltered on ascorbic acid 







































3. 6+1. 2 
I - Initial; 
Ascorbic Uric acid Uro-
acid mucoid 
0.5+0.2 3.l+o.9 2.6+1.l 
l.4+o .2a 3.1+1.0 2. 6+1.0 
l.4+0.2b 3.2+1.2 2.5+1.0 
l.3+o. 7b 3.0+o.9 2.5+o.9 
1. 5+0 .4b 3.2+1.2 2.5+1.0 
l.6+o.5b 2. 9+1.1 2.7+o.8 
1.4+0.5b 2.9+1.6 2.7+0.8 
1. 5+o. 4b 3.0+1.4 2 .8+1. 8 
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TABLE 2: Urine Chemistry (mg/24 hr) of Guinea Pigs Supplemented with 40 mg Ascorbic acid/100 gm Body 
Weight/day 
Days pH Creati- Calcium Oxalic Ascorbic Uric acid Uro- Inorg. Magne- Citric 
nine acid acid mucoid phos. sium acid 
-------------------------------------------------------------------------------------------------------
I 8.0+0.8 10.3+2.5 4.9+1.5 3. 0+1.1 0.4+0.02 2. 8+ 1. 1 2.5+1.0 6.0+2.3 2.4+0.9 2.2+0.7 
15 5.8+o.8c 10.9+3.5 4.5+1.8 3.9+1.2 2.4+1.0c 3.0+1.0 2.4+1.1 6.4+2.3 2.2+o.8 1. 7+o.8 
30 6.0+0.9c 10.8+3.8 4.4+1.9 3.9+1.2 2.4+1.0c 2. 7+1. 1 2.9+1.4 6.3+3.1 2.0+0.8 1.6+0 .6 
45 5.8+o.7c 11.0+3. 7a 4. 7+2.1 4.0+1. 1 2. 5+1. De 3.1+0.9 2.9+1.4 6.5+2.8 2.l+o.7 1.4+D.7a 
60 6.2+0.8c 10.9+4.1 4.2+2.la 4.3+1.2a 2.5+1.0c 3.0+0.9 2. 7+1.0 6.8+3.2 1.8+0. 7 1.3+0.5a 
75 5.9+o.9c 10. 9+4. 3 4.1+2.0a 4.2+1.3b 2.6+1.0c 2.9+1.0 3.0+l.5a 6. 7+2. 9 1. 2+1. Oa 1.2+0.5b 
90 5.3+o.4c 10.8+3.6 4.D+l.8a 4.8+1. 9b 2.5+o.9c 3.1+1.4 3.0+1.5 6.8+3.2 1.1+0 .4a 1.2+0.6b 
105 5.4+0.3c 10.9+4.1 3.8+1. 7b 4.8+1.9b 2.6+0.9c 3.8+4.4a 3.1+1.4 6.7+2.9 l.0+0.3c 1.0+0.4c 
I - Initial; a - p <D.05; b - p<0.02; C - p<0.001 
TABLE 3: Urine Chemistry (mg/24 hr) of Guinea Pigs Supplemented with 60 mg Ascorbic acid/100 gm Body 
Weight/day 
Days pH Creati- Calcium Oxalic Ascorbic Uric acid Uro- Inorg. Magne- Citric 
nine acid acid mucoid phos. sium acid 
-------------------------------------------------------------------------------------------------------
I 7.9+o.3 10.3+3.2 5.0+o.3 2.9+0.9 0.47+0.24 3.1+0.9 2.6+1.6 6.8+2.2 2.S+o.8 2 .0+0.8 
15 5.5+0.4c 10.4+4.l 4.6+2.0 3.8+1. l 3.9+0.9c 3.2+1. 1 2.9+1.6 6.8+2.9 2.2+0.9 0.8+0.4a 
30 5.5+o.3c 10. 7+4.3 4.4+2.0 4.3+1. 7a 4.4+0.8c 3.4+1.2 3.0+1.8 6.9+3.l 1.9+0.7a 1. O+D. 3a 
45 5.0+D.5c 10.3+4.9 4.0+1.8 4.5+2.la 4.3+1.0c 3.2+1.4 3.2+2.D 4.6+2.8 l.8+0.8a 0.8+0.5b 
60 5.5 0.6c 10. 9+4. 2 3.5+1.9a 4.9+1. 7a 4.4+1. lc 3.0+0. 9 3.9+1.0a 7.1+3.2 1.6+0.7b 0.8+D.4a 
75 5.5+0.7c 10.3+5.5 3.7+1.9 4.8+1. 3a 4.5+0.9c 3.3+0.9 3. 5+1. 3a 7.0+3.4 1.4+0.8b 0.9+0.4c 
90 5.5+o.5c 10.6+4.8 3.4+1.4a 4.9+2.0a 4.4+1. 7c 3.2+1.2 3.4+1.4 7.2+3.3 l.4+0.6b 0.6+D.3b 
105 5.5+0.3c 10.7+4.5a 3.4+1.4a 4.9+2. la 4. 7+1.0c 3. 4+1. 6 3. 4+1. 3 7.0+3.0 1. 2+0. 7b 0.7+0.2c 
I - Initial; a - p <0.05; b - p < 0.02; C - p < 0.001 
TABLE 4: Urine Chemistry (mg/24 hr) of Guinea Pigs Fed Normal Diet+ 2 % Calcium Carbonate 
Days pH Crea ti- Calcium Oxalic Ascorbic Uric acid Uro-





I 8.0+0.9 9.8+3.3 4.9+2.0 3.3+0.9 0.5+0.3 3.3+1.2 2.3+0.9 6.8+2.8 2.3+0.4 2.4+0.6 
15 7.5+0.8 10.6+4.4 6.2+3.0 2.8+1.6 0.4+o.2 3.7+1.9 2.5+1.2 6.6+2.4 1.6+0.4 1.6+0.7 
30 7.6+0.6 10.8+4.l 6.4+1.9 2.6+1.4 0.4+o.2 3.8+2.0 2.7+1.3 6.8+3.8 1.2+0.4 1.3+0.5 
45 7.5+o.7 10.5+3.9 6.5+1.9 2.8+1.5 o.5+o.2 3.6+1.7 2.9+1.3 6.7+2.9 1.2+0.4 1.2+0.5 
I - Initial 
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TABLE 5: Urine Chemistry (mg/24 hr) of Guinea Pigs Fed Normal Diet + 2% Calcium Carbonate + 10 mg 










acid acid mucoid 
I 7.9+0.6 10.2+4.l 4. 6+2. 1 3.2+o.8 0.4+0. l 3.S+o.8 2. 4+o. 9 6.6+2.9 2.2+o.7 2.6+0.8 
15 7.3+0.8a 9.8+4.2 6.3+3.l 2.9+1.2 0. 8+0. 4a3. 8+1. 3 2.4+1. 1 6.8+2.4 1. 4+0. 5 1.4+0.6 
30 7 .3+o.6a 10. 6+4. 4 6.5+3.2 3.0+1.0 l.O+o.Sa 3.9+1.4 2.9+o.9 6.9+3.2 1.2+0.4 1.3+0.6 
45 7.2+0.8a 10.4+4.3 6.5+3.2 3.0+1. l 1.1+0. Sa 3.9+1.4 3.1+0.9 6.7+2.8 1.1+0. 3 1.0+0.5 
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Uric acid Uro-
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2 . 4+ 1. 4 2 . 4+ 1. 1 
1.S+o.4 1.3+0.5 
1. 6+0 . 5 1. 4+0 . 6 
1.7+0.2 1.3+0.5 
I - Initial 
TABLE 7: Urine Chemistry (mg/24 hr) of Guinea Pigs Fed Normal Diet+ 3 % Sodium Oxalate Along with 10 










acid acid mucoid 
I 8. o+o .1 10.0+3.8 4.8+2.2 3. 8+1. 8 o. s+o .1 
15 7.2+0.5 10.5+4.l 3.0+1.l 4. 9+1. 3 l.0+0.4a 
30 7.3+o.6a 10.4+4.0 3.0+o.9 4.9+2.0 0.9+o.4a 
45 7.2+0.3a 10.8+2.9 3.2+1.0 4. 9+1. 8 0.9+0.Sa 
I - Initial; 
supplementation in sodium oxalate and calcium 
carbonate fed groups. 
Discussion 
The majority of urinary stones contained 
calcium oxalate (Smith, 1989) including those 
analysed by us (Hada et al. 1989; Pendse and 
Singh 1986; Pendse et al. 1987, 1984 and Singh 
et al. 1978). It is also unquestionably 
determined that oxalic acid is the most cogent 
risk factor in stone formation (Borsatti, 1991; 
Menon and Mahle, 1982). 
In human beings, ascorbate is the major 
source of oxalate (Hodgkinson, 1977). It is 
believed that the harmful effect of ascorbic 
acid in the human body lies in its conversion to 
oxalic acid generating a fear that higher intake 
may lead to enhanced oxalate production and 
3.8+1.8 2.4+o.9 7.1+3.5 2.4+1.3 2.5+0.l 
4.4+1.3 4.1+2.0 7.7+3.2 1. 3+0. 4 1.2+0.3 
4.2+1.4 4.3+1.8 7.9+3.0 1.3+0.3 1.2+0.4 
4.3+1.9 4.0+2.0 7.6+2.9 1.4+0.5 1.2+0.7 
a - p <0.05 
consequently synthesis of stones in urinary 
tract (Smith et al. 0978). Nevertheless, the 
issue remained unresolved because of the lack of 
any direct evidence of its involvement in the 
formation of stone in man or animal (Hoffer, 
1971 and Singh et al. 1988). 
In our extended experiment reported herein, 
10, 40, and 60 mg doses of ascorbic acid per kg 
body weight were given to guinea pigs. These 
doses theoretically correspond to 6, 24 and 36 g 
dose for a 60 Kg person and are in conformity 
with the doses advocated and given by many 
clinicians (Pauling, 1970; Hoffer, 1971). The 
experiment was conducted for 15 weeks. Taking 
the average life of guinea pigs as 3 years and 
that of man as 60 years, this period again 
theoretically corresponds to 7 years of human 
life. The normal ascorbic acid requirement of 
guinea pig is 0.5 mg/100 g body wt./day (Collins 
1044 
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Figure l(a). Calcium deposits in lumen of kidney tubule of guinea pigs fed sodium oxalate. 
(b) Intraluminal calcium deposits in kidney tubular and interstitial tissue of guinea pigs fed sodium 
oxalate+ ascorbic acid. (c) No effect of feeding sodium oxalate on bladder tissue. (d) Dense calcium 
deposits in cavity of bladder tissue of guinea pigs fed sodium oxalate+ ascorbic acid. 
and Elvehjen, 1958. Thus the selected doses of 
ascorbic acid were 20, 80 and 120 times to the 
normal requirement. This period and the doses 
were therefore, considered sufficient to judge 
the effect of chronic toxicity of this vitamin. 
Ascorbic acid showed its potential value in 
acidification of urine. Forty and 60 mg doses did 
affect the urinary profile. The possible 
explainations for these changes have already been 
given earlier (Singh et al. 1988 and 1987). The 
gross and histological examination did not 
indicate any crystal deposition, stone formation 
or calcification in kidney, ureter or bladder. 
All the findings taken together reconfirm 
our conclusions derived from rat experiments that 
ascorbic acid alone does not cause stone 
formation though it can increase oxaluria in 
higher doses. Since crystallization and 
aggregation process is dependent on net state of 
urinary chemical milieu; and that trapping of 
1045 
these crystals or aggregated crystals on a 
specific site of urinary tract· depends on 
assembly of multiple factors (Pak, 1987), it 
shall therefore be unreasonable to assume that 
hyperoxaluria alone can lead to stone formation. 
However, no one can deny the fact that 
hyperoxaluria makes urine nronitious to stone 
formation. It, therefore, would be logical to 
presume that in a stone former with preexisting 
stone risk, it will add to supersaturation 
and, therefore, can initiate stone formation or 
can cause renal calcification. Thus, ascorbic 
acid under such conditions may cause adverse 
effects. This would possibly explain the reason 
why in some patients metabolically inactive 
stone disease became active and also they 
developed new stones after regular consumption 
of ascorbic acid (Smith, et al. 1978). 
To verify the above hypothesis, we planned 
two experiments. In one set, a high calcium diet 
P.P. Singh, R. Kiran, A.K. Pendse et al. 
Figure 2 (a). Intraglomerular calcium deposits in guinea pigs fed calcium carbonate. (b) Intra-
glomerular and interstitial tissue calcium deposits in guinea pigs fed calcium carbonate + ascorbic 
acid. (c) Ulceration of mucosa with calcium deposit in the bladder of guinea pigs fed calcium carbonate. 
(d) Dense calcium deposits in the cavity of bladder of guinea pigs fed calcium carbonate + ascorbic 
acid. 
was given to animals. Half of these animals were 
also given 10 mg ascorbic acid/100 g body wt./ 
day. This experiment was planned keeping in view 
that in an affluent population, especially in 
industrialized countries, calcium intake is 
generally high. Calcium supplementation alone 
decreased the urinary oxalic acid significantly 
which should be due to decreased availability of 
oxalic acid for absorption in the intestine 
(Williams and Wandzilak, 1989) . In the ascorbic 
acid supplemented group, however, oxalic acid 
excretion remained unchanged suggesting the 
possibility that decrease in oxalate absorption 
could have been compensated by conversion of part 
of ascorbic acid to oxalic acid. The histological 
findings revealed that ascorbic acid supple-
mentation did not induce stone formation but 
intensified the renal calcification. 
During some periods of the year, oxalate 
1046 
intake is fairly high in this region and 
some other parts of India (Singh et al. 1990, 
1986 and 1972; Hodgkinson, 1977) and is 
considered to be etiologic factor (Pendse et al. 
1987 and 1984; Singh et al. 1992 and 1978). The 
ascorbic acid supplementation did not alter the 
urine chemistry in this set up also except that 
ascorbic acid excretion increased and pH 
decreased. However, histological examination 
once again showed the increased renal and 
bladder tissue calcification. 
The data of these two experiments taken 
together do suggest that ascorbic acid ingested 
in large doses increases the risk of renal 
calcification and chances of stone formation in 
preexisting hypercalciuric and hyperoxaluric 
conditions. 
Ascorbic acid and Urolithiasis 
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Discussion with Reviewers 
A.Hesse: Are the 3 % sodium oxalate given as a 
mixture with the food or dissolved in the 
drinking water (ad libitum)? 
Authors: It was given with diet. 
A.Hesse: Is it possible to establish a calcium 
and oxalate balance according to the intake of 
calcium and oxalate with the food? 
Authors: No. This study was not designed for 
this purpose. 
A.Hesse: What is the 24 hr urine volume of the 
animals like? 
Authors: Twenty four hr urinary output was not 
P.P. Singh, R. Kiran, A.K. Pendse et al. 
recorded because all the samples were collected 
in a bottle and material left behind was rinsed 
with double distilled water. Samples were 
finally made to 25 ml. 
A.Hesse: Is it possible to calculate stone risk 
factor (for example risk factor according to 
Robertson, the EQUIL-program by Finlayson or the 
calcium/citrate quotient)? 
Authors: Urinary calcium/citrate and calcium/ 
magnesium remained unaltered on ascorbic acid 
supplementation in sodium oxalate and calcium 
carbonate fed groups. Hence these data are not 
included in the tables. 
S.R.Khan: Did you look for crystalluria? 
Authors: Yes. Ascorbic acid in neither of the 
doses affected urinary crystalluria. 
S.R.Khan: Whether the calcification is intra-
luminal or intracellular and whether it was due 
to calcium phosphate or calcium oxalate? 
Authors: It is intraluminal. Since we have not 
examined the crystals under polarised microscope, 
we cannot authentically comment on it. 
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